4//SEC Filing
Zack Debra 4
Accession 0001274737-21-000009
CIK 0001274737other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:05 PM ET
Size
7.7 KB
Accession
0001274737-21-000009
Insider Transaction Report
Form 4
EXAGEN INC.XGN
Zack Debra
Chief Medical Officer
Transactions
- Award
Stock Option(right to buy)
2021-02-23+12,500→ 12,500 totalExercise: $18.20Exp: 2031-02-22→ Common Stock (12,500 underlying) - Award
Common Stock
2021-02-23+37,500→ 37,500 total
Footnotes (3)
- [F1]Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2020, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control.
- [F2]Represents 37,500 shares of restricted stock units.
- [F3]The option is exercisable as it vests. 25% of the shares subject to the option vest on February 23, 2022, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control.
Documents
Issuer
EXAGEN INC.
CIK 0001274737
Entity typeother
Related Parties
1- filerCIK 0001807743
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:05 PM ET
- Size
- 7.7 KB